Lab-Made antibodies target each Patient's unique cancer cells
NCT ID NCT06674538
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 26 times
Summary
This early-stage study tests whether antibodies made from a patient's own tumor can safely help the body kill cancer cells. Up to 12 adults with stage IV soft tissue cancer will receive personalized infusions. The goal is to see if these custom antibodies are safe and can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.